Startseite>>Signaling Pathways>> Membrane Transporter/Ion Channel>> P-glycoprotein>>Tariquidar dihydrochloride

Tariquidar dihydrochloride (Synonyms: XR9576 dihydrochloride)

Katalog-Nr.GC50254

Tariquidar-Dihydrochlorid (XR9576-Dihydrochlorid) ist ein potenter und spezifischer Inhibitor von P-Glykoprotein (P-gp) mit hoher AffinitÄt (Kd = 5,1 nM).

Products are for research use only. Not for human use. We do not sell to patients.

Tariquidar dihydrochloride Chemische Struktur

Cas No.: 1992047-62-7

Größe Preis Lagerbestand Menge
10 mg
319,00 $
Auf Lager
50 mg
1.341,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Potent P-glycoprotein (P-gp) inhibitor (IC50 = 5.1 nM). Reverses drug resistance in multiple MDR cell lines. Acts as a substrate for breast cancer resistance protein (BCRP) at low concentrations and acts as an inhibitor of BCRP when used at >100 nM concentration. Potentiates the cytotoxic effects of doxorubicin and mitoxantrone in vitro.

Kannan et al (2011) The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2). ACS Chem.Neurosci. 2 82 PMID:22778859 |Loo et al (2015) Mapping the binding site of the inhibitor Tariquidar that stabilizes the first transmembrane domain of P-glycoprotein. J.Biol.Chem. 290 29389 PMID:26507655

Bewertungen

Review for Tariquidar dihydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tariquidar dihydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.